US Biotech Market Analysis

US Biotech Market Analysis

The report ``US Biotech Market Analysis” provides an updated and detailed overview of the U.S Biotechnology industry. It examines the emerging trends and provides exclusive forecasts, segment wise snapshots of biotechnology industry in U.S.

Key Findings

§ Growing at the rate of 13.95% from the year 2005, U.S Biotechnology industry is expected to touch the mark of US$ 131.8 Billion by the end of 2010.
§ Biotechnology will play an important role in Agricultural sector by developing large number of genetically modified seeds.
§ The biomedical sector accounts for the major share of overall biotech industry in US and will continue to dominate in future as well.
§ The clinical trial industry will cross US$ 30 Billion mark by 2011.

Key Issues and Facts Analyzed

The research report also addresses the issues and facts that are critical to your success:

§ Major market trends in the US Biotechnology industry?
§ Where will the market be after 5 years?
§ What opportunities exist in US Biotechnology industry?
§ What are the driving factors for the US Biotechnology industry?
§ Challenges faced by Biotechnology industry?
§ Who are the main players in the US Biotechnology industry?

Key Players Analyzed

This section provides the overview, key facts financial information of prominent players in the Indian Biotechnology Industry like Chiron Corporation, Amgen Inc., Biogen Idec Inc., Applied Biosystems, Genentech, and Baxter International Inc.

Research Methodology Used

Information Sources
Information has been sourced from namely, books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to access to more than 3000 paid databases.

Analysis Methods
The analysis methods include the following: Ratio Analysis, Historical Trend Analysis, Linear Regression Analysis using software tools, Judgmental Forecasting and Cause and Effect Analysis.

1. Analyst View
2. Research Overview
3. Industry Overview
3.1 Biotechnology Industry Worldwide
3.2 US Biotech Industry
4. Industry Performance
4.1 Bio Medical
4.1.1 Current Biomedical Business Models
4.1.1.1 Fully Integrated Companies (FICOs: FIPCOs, FIBCOs, FICOPs)
4.1.1.2 Non Research Development Only (NRDOs)
4.1.1.3 Platform Model
4.1.1.4 Mixed Models
4.1.1.5 Medical Device Model
4.1.2 Stages of Growing Biomedical Firm
4.2 Agriculture Biotechnology
4.2.1 Production and Economic Impacts
4.2.2 Adoption of Biotechnology Derived Crops
4.2.3 Biotechnology and Biofuels
4.3 Clinical Trials
4.4 Mergers and Acquisitions
4.5 Strategic Alliances
4.6 Biotech Funding (Public, Private & Venture Capital)
4.7 Biotech Research Parks
4.7.1 Cummings Research Park, Huntsville
4.7.2 ASU (Arizona State University) Research Park
4.7.3 Texas Research Park
4.7.4 Delaware Technology Park
4.7.5 Massachusetts Biotechnology Research Park
4.7.6 UK (University of Kentucky) Coldstream Research Campus
4.7.7 InterTech Science Park
4.7.8 Chicago Technology Park
5. US Bio Cluster
5.1 New York
5.2 North-West Pennsylvania
5.3 Massachusetts
5.4 California
5.5 Washington
6. Industry Analysis
6.1 Key Drivers
6.1.1 Increasing Financing Option
6.1.2 Strong and Stable Biotech Sector
6.1.3 Environmental Drivers
6.1.4 Sociological Drivers
6.1.5 Patent System
6.1.6 Federal Funding
6.1.7 FDA Biopharmaceuticals Approvals
6.1.8 Technology
6.2 Opportunities
6.2.1 Opportunity for Developers of Innovative Health Solutions
6.2.2 Biofertilizers/BioPesticides
6.2.3 Agricultural Biotechnology
6.2.4 Biofuel
6.3 Challenges
6.3.1 Consumer Preferences & Market Uncertainty
6.3.2 Cost Pressures
6.3.3 Competition from Developing Countries like India & China
6.3.4 Public Acceptance
6.4 Future Outlook, 2010
7. Key Players and Company Profiles
7.1 Chiron Corporation
7.2 Amgen Inc.
7.3 Biogen Idec, Inc.
7.4 Applied Biosystems
7.5 Genentech
7.6 Baxter International Inc.
8. Annexure I: Government Initiatives and Regulations
8.1 Food and Drug Administration (FDA)
8.1.1 Food
8.1.2 Regulation of Drugs and Biologic Products
8.2 United States Department of Agriculture (USDA)
8.3 United States Environmental Protection Agency (USEPA)

List of Figures:

Figure 3-1: Global - Biotechnology Market (in Billion US$), 2001-2005
Figure 3-2: Global - Biotechnology Market Share by Region (%), 2005
Figure 3-3: Global - Biotechnology Market Share by Segment (%), 2005
Figure 3-4: Global - Forecast for Biotechnology Market (in Billion US$), 2006-2010
Figure 3-5: US - Biotechnology Market (in Billion US$), 2001-2006E
Figure 3-6: US - Biotechnology Market Share by Segment (%), 2005
Figure 3-7: US - Distribution Companies by Segment (%), 2005
Figure 4-1: US - Net Loss Relative to Revenue (%), 1991-2005
Figure 4-2: US - Employment in Biomedical Sector (%), 2005
Figure 4-3: US - Interaction among Players in Biomedical and Healthcare Industries
Figure 4-4: US - Forecast for Clinical Trial Industry (in Billion US$), 2006-2011
Figure 4-5: US - Clinical Trials (in Numbers), 2003-2006E
Figure 4-6: US - Forecast for Clinical Trials (in Number), 2007-2011
Figure 4-7: US - Biotech Financing (in Billion US$), 2004-2006E
Figure 6-1: US - Biotech Financing (in Billion US$), 2004 & 2005
Figure 6-2: US - FDA Approvals (in Numbers), 2000 to Jun’ 2006
Figure 6-3: US - Ethanol Demand (in Billion Gallons), 2006-2008E
Figure 6-4: US - Forecast for Biotech Market (in Billion US$), 2007-2010

List of Tables:

Table 3-1: Biotechnology Industry Segments and Applications
Table 4-1: US - Regulatory History of Biomedical Industry
Table 4-2: US - Stages for Biomedical Companies
Table 4-3: US - Overall Impact of Biotechnology Derived Crops on Agriculture (2001 & 2003 to 2005)
Table 4-4: US - Percentage Adoption of Biotechnology Derived Crops (2003-2005)
Table 4-5: US - Impact of Biotechnology on Crops (Production & Pesticides Reduction), 2005
Table 4-6: US - Impact of Agricultural Biotechnology on Crops, 2005
Table 4-7: US - Impact of Bitechnology Corn on Grain and Ethanol Production (1996-2005)
Table 4-8: US - Selected Biotech M&As (in Million US$), 2005
Table 4-9: US - Biotech Alliances (in Million US$), 2005
Table 4-10: US - Biotech Financing (in Million US$), 2004 & 2005
Table 5-1: Massachusetts - List of FDA Approved Biotechnology Products
Table 6-1: US - FDA Approvals by Drug Name, Company & Type
Table 7-1: Amgen Inc. - Key Financials (in Million US$), 2004 to Sep’ 2006
Table 7-2: Biogen Idec, Inc. - Key Financials (in Million US$), 2004 to Sep’ 2006
Table 7-3: Applied Biosystems - Key Financials (in Billion US$), June’ 2006
Table 7-4: Genentech - Key Financials (in Million US$), 2004 to Sep’ 2006
Table 7-5: Baxter International Inc. - Key Financials (in Million US$), 2005 & Sep’ 2006
Table 8-1: US - Federal Biotechnology Regulatory Framework